Table 6.
Coverage of key clinical interventions in the four study hospitals
| Egypt | Lebanon | Palestine | Syria | All | |
|---|---|---|---|---|---|
| Al Galaa Hospital | Rafik Hariri University Hospital | Ramallah Hospital | Dar Al Tawleed Hospital | ||
| N (%) | N (%) | N (%) | N (%) | N (%) | |
| Coverage of prophylactic oxytocin among all who delivered at hospital | 1921/2736(70.2) | 1171/1178 (99.4) | 1119/1234 (90.7) | 3967/4007 (99) | 8178/9423 (86.8 ) |
| Coverage of therapeutic oxytocin among near-miss cases with postpartum haemorrhage | 3/3 (100) | 1/1 (100) | 5/6 (83.3) | 4/4 (100) | 13/14 (92.9) |
| Coverage of blood products among near-miss cases with postpartum haemorrhage | 3/3 (100) | 1/1 (100) | 6/6 (100) | 4/4 (100) | 14/14 (100) |
| Coverage of magnesium sulphate among near-miss cases with eclampsia | 2/2 (100) | 1/1 (100) | 1/1 (100) | 1/1 (100) | 5/5 (100) |
| Coverage with any other anticonvulsant among near-miss cases with eclampsia | 0/2 (0) | 1/1 (100) | 1/1 (100) | N/A | 2/4 (50) |
| Coverage of prophylactic antibiotics among women with caesarean section | 1238/1488 (83.2) | 427/432 (98.8) | 275/307 (89.6) | 913/913 (100) | 2853/3140 (90.9) |
| Coverage of parenteral antibiotics among maternal misses with sepsisa | N/A | N/A | N/A | N/A | N/A |
| Coverage with laparotomy among near-miss cases with uterine rupture | 1/4 (25) | N/A | 1/1 (100) | 2/2 (100) | 4/8 (50) |
aNo sepsis cases were reported